國家衛生研究院 NHRI:Item 3990099045/7602
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857752      線上人數 : 792
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7602


    題名: Pharmacogenomics study in a Taiwanese methadone maintenance cohort
    作者: Wang, SC;Tsou, HH;Ho, IK;Lin, KM;Liu, YL
    貢獻者: Center for Neuropsychiatric Research;Division of Biostatistics and Bioinformatics
    摘要: Pharmacogenomics is the study of drug treatment responses in subgroups of patients on the basis of their genetic variants or genetic expression information. In 2006, the government of Taiwan launched a methadone maintenance treatment program, which is usually prescribed for patients with heroin dependence. In this study, 366 patients who had taken methadone continually in the previous 7 days were examined. Data from the Treatment Outcomes Profile (TOP), Severity of Dependence Scale (SDS), Clinical Opioid Withdrawal Scale (COWS), and Treatment Emergent Symptoms Scale (TESS) were obtained from the patients' report records. The genes CYP2B6, CYP3A4, and CYP2C19—which encode the liver cytochrome P-450 (CYP) enzymes that are involved in the metabolism of methadone—were selected and genotyped in this cohort. We found that single nucleotide polymorphisms (SNPs) on the CYP2B6 gene were associated with the plasma S-methadone concentration. The SNPs on the CYP3A4 gene were associated with withdrawal symptoms and side effects. The SNPs on the CYP2C19 gene were associated with the methadone dose. The SNPs in the genes (e.g., UGT2B7) encoding the morphine phase II metabolic enzyme were associated with the withdrawal symptom scores. In pharmacodynamic genes, the SNPs on the OPRM1 gene were associated with the side effects of insomnia and change in libido. We conclude that SNP markers may be useful in the future for adjusting methadone dosage and for reducing adverse reactions.
    日期: 2013-12
    關聯: Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
    Link to: http://dx.doi.org/10.1016/j.jfda.2013.09.036
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1021-9498&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000329422800020
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84897028730
    顯示於類別:[劉玉麗] 期刊論文
    [林克明(2004-2009)] 期刊論文
    [何英剛(2006-2011)] 期刊論文
    [王聲昌] 期刊論文
    [鄒小蕙] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SDO1021949813001002.pdf644KbAdobe PDF843檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋